Jayson Bedford
Stock Analyst at Raymond James
(4.64)
# 835
Out of 4,356 analysts
732
Total ratings
59.4%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintained: Buy | $128 → $150 | $128.64 | +16.60% | 13 | May 8, 2026 | |
| PODD Insulet | Maintained: Buy | $360 → $263 | $144.94 | +81.45% | 45 | May 7, 2026 | |
| DXCM DexCom | Maintained: Buy | $102 → $81 | $73.74 | +9.85% | 74 | May 1, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $102 → $83 | $63.06 | +31.62% | 45 | May 1, 2026 | |
| AXGN Axogen | Maintained: Buy | $41 → $48 | $39.48 | +21.58% | 8 | Apr 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $124 → $88 | $48.31 | +82.16% | 76 | Mar 27, 2026 | |
| MASI Masimo | Downgraded: Hold | n/a | $178.45 | - | 10 | Mar 27, 2026 | |
| SYK Stryker | Upgraded: Buy | $418 | $305.09 | +37.01% | 4 | Jan 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Downgraded: Hold | n/a | $82.33 | - | 9 | Jan 6, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $96 | $86.47 | +11.02% | 30 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $592 → $603 | $424.64 | +42.00% | 15 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $18.45 | +2.98% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $141 → $146 | $85.60 | +70.56% | 84 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $164 → $209 | $225.33 | -7.25% | 68 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $73.81 | - | 29 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $180 | $135.39 | +32.95% | 59 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $6.79 | - | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $18.78 | - | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.04 | - | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $147.12 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.89 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.20 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $11.48 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
Teleflex
May 8, 2026
Maintained: Buy
Price Target: $128 → $150
Current: $128.64
Upside: +16.60%
Insulet
May 7, 2026
Maintained: Buy
Price Target: $360 → $263
Current: $144.94
Upside: +81.45%
DexCom
May 1, 2026
Maintained: Buy
Price Target: $102 → $81
Current: $73.74
Upside: +9.85%
Merit Medical Systems
May 1, 2026
Maintained: Buy
Price Target: $102 → $83
Current: $63.06
Upside: +31.62%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $41 → $48
Current: $39.48
Upside: +21.58%
Boston Scientific
Mar 27, 2026
Maintained: Buy
Price Target: $124 → $88
Current: $48.31
Upside: +82.16%
Masimo
Mar 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $178.45
Upside: -
Stryker
Jan 6, 2026
Upgraded: Buy
Price Target: $418
Current: $305.09
Upside: +37.01%
Zimmer Biomet Holdings
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $82.33
Upside: -
Edwards Lifesciences
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $86.47
Upside: +11.02%
Oct 22, 2025
Maintained: Buy
Price Target: $592 → $603
Current: $424.64
Upside: +42.00%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $18.45
Upside: +2.98%
Oct 16, 2025
Maintained: Buy
Price Target: $141 → $146
Current: $85.60
Upside: +70.56%
Oct 15, 2025
Maintained: Buy
Price Target: $164 → $209
Current: $225.33
Upside: -7.25%
Aug 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $73.81
Upside: -
Aug 8, 2025
Maintained: Buy
Price Target: $187 → $180
Current: $135.39
Upside: +32.95%
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $6.79
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $18.78
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $16.04
Upside: -
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $147.12
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $15.89
Upside: n/a
May 4, 2023
Maintained: Hold
Price Target: n/a
Current: $17.20
Upside: n/a
Apr 17, 2023
Maintained: Buy
Price Target: $14 → $13
Current: $11.48
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a